With the exception of targeting AKT signaling, studies also indicated that modulating the p38/ERK pathways could lead to the permanent growth arrest of quiescent cells (senescent), thus preventing tumor recurrence and metastasis [64]. The gene discussed is AKT1; the disease is neoplasm.